A World Health Organization advisory committee on editing human DNA will ask the United Nations agency to establish a global registry of all such research, recommend that editors of scientific journals not publish any unregistered studies, and ask science funders to require that their grantees register their studies, committee co-chair Dr. Margaret Hamburg told reporters on Tuesday.

The registry would include studies that edit the DNA of eggs, sperm, and early embryos, called germline editing, and those that edit adult cells for the purpose of curing disease, which is much less controversial and is the focus of all genome-editing companies.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Can we please bring back Frances Oldham Kelsey from the dead, and put her in charge instead? One woman at FDA saved the USA from the tragedy of thalidomide babies.

    The other woman led FDA through lots of approvals not always standing the test of time. Also, read the FDA archives about the longest delayed, most curious classification of a medical device in US history, completed in 2009. She perpetuated the tragedy of bioaccumulation of mercury in genetically susceptible children and adults who do not methylate well. Read the latest scientific literature on dental amalgam health impacts, especially published outside the US.

    Why do we have a Class II ruling with special controls for dental amalgam, with manufacturers required to inform dentists of its 50% mercury content, health risks, warnings and contraindications and a skull and crossbones on the MSDS – but no printed information, or written informed consent, required from dentist to patient?

    Why is mercury dental amalgam increasingly banned, restricted and being phased out aggressively in a growing number of advanced and developing nations, yet protected from media coverage in the US?

    Follow the money, past patents, board seats. and history of the Amalgam Wars in the US and elsewhere. Read the testimony of genetically susceptible patients, hygienists and dentists themselves with neurological and multisystemic harm from dental mercury toxicity over time.

    We treat people with alcohol poisoning or drug addiction. We do not treat people with dental mercury toxicity from dental devices installed without their right to know information or written informed consent. Health insurance will cover removing a medical device causing harm. It will not cover removing dental devices causing harm. Neither will dental insurance.

    Something is wrong with this picture. One of these women helped paint it. Now, can she please help fix it?

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy